TEL AVIV, July 26- After months of sparring in a hostile takeover bid for rival Mylan NV, Teva Pharmaceutical's move to buy Allergan Plc's generic drug business instead could be a smoother ride that will bring bigger returns, faster. Israel- based Teva, the world's largest generic drugmaker, is in advanced talks to buy Allergan's generic drugs unit for between $40-...» Read More
Human Genome Sciences rejected the $2.6 billion unsolicited takeover bid from GlaxoSmithKline, reports CNBC's Herb Greenberg.
CNBC's Kayla Tausche reports on Illumina playing offense against Roche's hostile takeover bid, and the FMHR crew share their final trades of the hour.
CNBC's David Faber reports the latest details on Illumina's recommendation to shareholders to reject Roche's takeover offer.
Mad Money host Jim Cramer shares his final thoughts on the future of tech giants, Research in Motion and Yahoo.
The Fast Money traders weigh in on how to play unusual options activity in Avon's shares on Monday.
CNBC's Brian Shactman breaks down today's big movers including two downgrades at Stifel Nicolaus, and Avon's rejection of a takeover bid from Coty.
Karen Finerman, Metropolitan Capital Advisors, and Fast Money trader, provides insight on what's next for Illumina, on the heels its recent rejection of Roche's offer.
Cramer ticks off the many winning trades today.
Keith Moore, MKM Partners, discusses how to play Roche's hostile bid for gene sequencer, Illumin, saying ILMN is likely to fight the takeover. Also an update on SanDisk's earnings, with the Fast Money crew.
Fast Money trader Karen Finerman explains what's behind Roche's tender offer for Illumina; and the best way to play the biotech takeout trend.
Is Netflix a possible takeover candidate by Yahoo? Gene Munster, Piper Jaffray, and the Fast Money traders, weigh in on the rumor, and the possible play on the stocks, and options activity. Also a paid to wait options strategy on Yahoo, with Pete Najarian, Fast Money trader.
The Fast Money traders weigh in on possible suitors for RIM, including, Amazon. Also, the play on Jefferies, as shares surge more than 20% on better-than-expected earnings.
Fast Money trader, Karen Finerman takes a closer look at the hostile takeover attempt by Martin Marietta Materials for Vulcan Materials.
How to trade the cloud-computing space, with Dan Ives, FBR Capital Markets, and the Fast Money traders.
The Fast Money traders weigh in on a takeover bid of $3 per share for Talbots by private equity firm, Sycamore Partners.
Billionaire investor Carl Icahn discusses why he has taken his takeover bid directly to CMC shareholders, and the difference between this bid and his takeover attempt of Clorox. Icahn also weighs in on a possible Navistar/Oshkosh merger, the presidential election, and the U.S. economy.
In a special Veteran's Day show, former U.S. Marine, and Clorox CEO, Donald Knauss, discusses his company's healthy 3.7% yield and strong earnings, with Mad Money host, Jim Cramer.
Mad Money's Jim Cramer talks with Peter McCausland, Airgas Inc. CEO, about its success fending off a hostile takeover bid from Air Products, and the company's bright future.
Mad Money's Cramer says investors can always fall back on high-yielding dividend stocks that pay you to wait, like Clorox. Discussing the future of the company, now that it turned down Carl Icahn's $80/share bid, with Donald Knauss, Clorox CEO.
Mike Khouw, Cantor Fitzgerald with the options play on rumors billionaire investor Warren Buffett is taking a stake in Whirlpool.